Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas

被引:0
|
作者
Richard Huan Xu
Eliza Lai Yi Wong
Jun Jin
Ying Dou
Dong Dong
机构
[1] The Chinese University of Hong Kong,The Jockey Club School of Public Health and Primary Care, Faculty of Medicine
[2] Centre for Health Systems and Policy Research,Department of Sociology, School of Social Sciences
[3] The Chinese University of Hong Kong,undefined
[4] Tsinghua University,undefined
[5] Shenzhen Research Institute,undefined
[6] The Chinese University of Hong Kong,undefined
关键词
EORTC QLQ-C30; EQ-5D-5L; Mapping algorithm; Lymphoma; China;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1363 / 1373
页数:10
相关论文
共 50 条
  • [21] Quality of Life of Cancer Patients during Chemotherapy in Indonesia: A Comparison of EORTC QLQ-C30 and EQ-5D-5L, Based on Patients' Characteristics
    Perwitasari, Dyah A. A.
    Purba, Fredrick D. D.
    Candradewi, Susan F. F.
    Dania, Haafizah
    Irham, Lalu Muhammad
    Faridah, Imaniar Noor
    Septiantoro, Bayu P. P.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [22] UTILITY MAPPING OF THE EORTC QLQ-C30 ONTO EQ-5D IN PATIENTS WITH SOFT TISSUE SARCOMA
    Amdahl, J.
    Manson, S. C.
    Isbell, R.
    Chit, A.
    Delea, T. E.
    VALUE IN HEALTH, 2013, 16 (07) : A419 - A419
  • [23] Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer (vol 21, 1237, 2021)
    Gray, Laura A.
    Hernandez Alava, Monica
    Wailoo, Allan J.
    BMC CANCER, 2022, 22 (01)
  • [24] Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
    Iftekhar Khan
    Steve Morris
    Nora Pashayan
    Bashir Matata
    Zahid Bashir
    Joe Maguirre
    Health and Quality of Life Outcomes, 14
  • [25] Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients
    Khan, Iftekhar
    Morris, Steve
    Pashayan, Nora
    Matata, Bashir
    Bashir, Zahid
    Maguirre, Joe
    HEALTH AND QUALITY OF LIFE OUTCOMES, 2016, 14
  • [26] Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
    Brett Doble
    Paula Lorgelly
    Quality of Life Research, 2016, 25 : 891 - 911
  • [27] Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms
    Doble, Brett
    Lorgelly, Paula
    QUALITY OF LIFE RESEARCH, 2016, 25 (04) : 891 - 911
  • [28] Mapping the cancer-specific QLQ-C30 onto the generic EQ-5D-5L and SF-6D in colorectal cancer patients
    Ameri, Hosein
    Yousefi, Mahmood
    Yaseri, Mehdi
    Nahvijou, Azin
    Arab, Mohammad
    Sari, Ali Akbari
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2019, 19 (01) : 89 - 96
  • [29] NAVIGATING INDIRECT UTILITY MODELS IN CANCER: MAPPING THE EORTC QLQ-C30 ONTO THE EQ-5D
    Doble, Brett
    Harris, Anthony
    Lorgelly, Paula
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2013, 9 : 121 - 121
  • [30] Testing alternative regression models to predict utilities: mapping the QLQ-C30 onto the EQ-5D-5L and the SF-6D
    Admassu N. Lamu
    Jan Abel Olsen
    Quality of Life Research, 2018, 27 : 2823 - 2839